Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
Connectivity is a lifeline for refugees
01/16/2017. Globally, refugees are 50 per cent less likely than the general population to have an internet-enabled phone, and 29 % of refugee households have no phone at all. This must change, by Filippo Grandi.
Nigeria: Health worker Hauwa Mohammed Liman executed in captivity
10/16/2018. A second health worker held hostage in Nigeria has been murdered.
How Settlement Businesses Contribute to Israel’s Violations of Palestinian Rights
01/20/2016. In this report, Human Rights Watch note that by virtue of doing business, companies contribute to one or more of these violations of international humanitarian law and human rights abuses.
